Hereditary Hemochromatosis Manifesting After Treatment of Paroxysmal Nocturnal Hemoglobinuria With Eculizumab

被引：0

作者：

Elliott, Elizabeth ^{[1
]}

Waheed, Salman ^{[2
]}

Syed, Sahr ^{[3
]}

Eswaran, Sheila ^{[4
]}

Gregory, Stephanie ^{[5
]}

Shammo, Jamile ^{[5
]}

机构：

[1] Rush Univ, Med Ctr, Dept Internal Med, 1653 W Congress Pkway, Chicago, IL 60612 USA

[2] Rush Univ, Med Ctr, Div Hematol & Oncol, Chicago, IL 60612 USA

[3] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA

[4] Rush Univ, Med Ctr, Sect Hepatol, Chicago, IL 60612 USA

[5] Rush Univ, Med Ctr, Sect Hematol, Chicago, IL 60612 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷 / 01期

关键词：

Anticomplement C5 therapy; Hemoglobinuria; Hemolysis; Iron metabolism; Iron overload; APLASTIC-ANEMIA; DIAGNOSIS; GUIDELINES; MANAGEMENT; IRON;

D O I：

10.1016/j.clml.2017.09.021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：E9 / E12

页数：4

共 50 条

[31] Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerations
Al-Ani, Fatimah
Chin-Yee, An
Lazo-Langner, Alejandro
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1161 - 1170
[32] Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab
de Latour, Regis Peffault
Fremeaux-Bacchi, Veronique
Porcher, Raphael
Xhaard, Alienor
Rosain, Jeremie
Castaneda, Diana Cadena
Vieira-Martins, Paula
Roncelin, Stephane
Rodriguez-Otero, Paula
Plessier, Aurelie
de Fontbrune, Flore Sicre
Abbes, Sarah
Robin, Marie
Socie, Gerard
BLOOD, 2015, 125 (05) : 775 - 783
[33] Paroxysmal nocturnal hemoglobinuria and pregnancy before the eculizumab era: the French experience
de Guibert, Sophie
de Latour, Regis Peffault
Varoqueaux, Nathalie
Labussiere, Helene
Rio, Bernard
Jaulmes, Dominique
Eveillard, Jean-Richard
Dulucq, Stephanie
Stoppa, Anne-Marie
Bouscary, Didier
Girodon, Francois
Bonnotte, Bernard
Laskri, Djamila
Socie, Gerard
Lamy, Thierry
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (09): : 1276 - 1283
[34] Eculizumab before and after allogeneic hematopoietic stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria
Goker, Hakan
Uz, Burak
Buyukasik, Yahya
Aksu, Salih
Haznedaroglu, Ibrahim
Sayinalp, Nilgun
Karacan, Yasemin
Tekin, Fatma
Ozcebe, Osman Ilhami
TURKISH JOURNAL OF HEMATOLOGY, 2011, 28 (03) : 223 - 227
[35] Iptacopan for the treatment of paroxysmal nocturnal hemoglobinuria
de Castro, Carlos M.
Patel, Bhumika J.
EXPERT OPINION ON PHARMACOTHERAPY, 2024, : 2331 - 2339
[36] Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival
Kelly, Richard J.
Hill, Anita
Arnold, Louise M.
Brooksbank, Gemma L.
Richards, Stephen J.
Cullen, Matthew
Mitchell, Lindsay D.
Cohen, Dena R.
Gregory, Walter M.
Hillmen, Peter
BLOOD, 2011, 117 (25) : 6786 - 6792
[37] Successful Use of Eculizumab in a Pediatric Patient Treated for Paroxysmal Nocturnal Hemoglobinuria
Bauters, Tiene
Bordon, Victoria
Robays, Hugo
Benoit, Yves
Dhooge, Catharina
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2012, 34 (08) : E346 - E348
[38] Paroxysmal Nocturnal Hemoglobinuria: Biology and Treatment
Bravo-Perez, Carlos
Guarnera, Luca
Williams, Nakisha D.
Visconte, Valeria
MEDICINA-LITHUANIA, 2023, 59 (09):
[39] Effect of eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria with or without high disease activity: Real-world findings from the International Paroxysmal Nocturnal Hemoglobinuria Registry
Hoechsmann, Britta
de Fontbrune, Flore Sicre
Lee, Jong Wook
Kulagin, Alexander D.
Hillmen, Peter
Wilson, Amanda
Marantz, Jing L.
Schrezenmeier, Hubert
EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (03) : 197 - 204
[40] Pathophysiology, diagnosis, and treatment of paroxysmal nocturnal hemoglobinuria: a review
Devalet, Berangere
Mullier, Francois
Chatelain, Bernard
Dogne, Jean-Michel
Chatelain, Christian
EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (03) : 190 - 198

← 1 2 3 4 5 →